The differences rate of EGFR mutations were associated with patients’ sex (p = 0.02), adenocarcinoma (p < 0.01), TNM stage (p < 0.01), and brain metastasis (p < 0.01). The gene discussed is EGFR; the disease is adenocarcinoma.